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Taking the MOLST (Medical Orders for
Life-Sustaining Treatment) Statewide
Robert S. Olick, Joel Potash & Amy T. Campbell*
On July 7, 2008, New York Governor David A. Paterson
signed into law an initiative to make permanent and to extend
statewide the use of Medical Orders for Life-Sustaining Treatment (“MOLST”) to document physician orders to carry out decisions near the end of a patient’s life.1 The MOLST form has
been used under a demonstration project in Onondaga and
Monroe Counties since 2006.2 The MOLST program and corresponding form (known as the “pink form”) were developed by
upstate New York insurer Excellus BlueCross BlueShield (“Excellus”) and the Community-Wide End-of-Life/Palliative Care
Initiative under the leadership of Dr. Patricia Bomba, Vice
President and Medical Director (Geriatrics) for Excellus.3
For the most part, the purpose of the MOLST legislation is
to direct health care providers, patients, and families to use the
MOLST form to implement existing laws governing decisions
* Robert S. Olick, J.D., Ph.D., Joel Potash, M.D., and Amy T. Campbell, J.D.,
M.B.E., are faculty members in the Center for Bioethics and Humanities, SUNY
Upstate Medical University.
1. Act of July 7, 2008, ch. 197, 2008 N.Y. Laws 197 (codified as amended at
N.Y. PUB. HEALTH LAW § 2977(13) (McKinney Supp. 2009)). See also Robert S.
Olick, Legislative Watch, BIOETHICS IN BRIEF (SUNY Upstate Med. Univ., Ctr. for
Bioethics & Humanities, Syracuse, N.Y.), Sept. 2008, at 4, available at http://www.
upstate.edu/bioethics/bnb_8_2008.pdf (discussing the passage of amendment to
New York Public Health Law that recognizes the use of MOLST statewide); Press
Release, Excellus BlueCross BlueShield, Gov. Paterson Signs End-of-Life Program
into Law (July 9, 2008), available at http://www.nysvara.org/news/2008/jul/
080709.pdf.
2. Prior to the passage of the MOLST, Do Not Intubate (“DNI”) orders could
not be honored in pre-hospital settings by emergency medical service (“EMS”) personnel. See Excellus BlueCross BlueShield, supra note 1. However, legislation in
2006 amended N.Y. PUB. HEALTH LAW § 2977(13), authorizing EMS personnel in
Monroe and Onondaga Counties to honor DNI orders for patients while still en
route to the hospital. Act of July 26, 2006, ch. 325, 2006 N.Y. Laws 325 (current
version at N.Y. PUB. HEALTH LAW § 2977(13)).
3. Excellus BlueCross BlueShield, supra note 1. A copy of the primary
MOLST form is attached as Appendix A.
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near the end of life.4 Although the legislation is new to New
York, the program creates no new substantive rights to refuse
life-sustaining treatment, except with respect to Do-Not-Intubate (“DNI”) orders.5 The MOLST initiative facilitates patients’
rights to execute out-of-hospital Do-Not-Resuscitate (“DNR”) orders, establishes a new patient right to DNI orders, and makes
plain a correlative duty of emergency medical personnel to
honor DNI orders in the patient’s home and elsewhere.6 This
article explains the nature and purpose of the MOLST program,
placing it in the context of the surrounding New York law. We
address the goals of the MOLST initiative and identify some
challenges and legal barriers to its full and effective
implementation.
More than 147,000 New Yorkers die each year, with more
than 110,000 of those deaths occurring in hospitals, nursing
homes, and other institutions across the state.7 On a national
level, approximately seventy percent of hospital deaths occur after a decision to withhold or withdraw life-sustaining treatment.8 Considering that patients die every day after a decision
to withhold or withdraw life-sustaining treatment has been
made, the MOLST form will likely have a wide impact on how
people die in the Empire State.
I. The MOLST Legislation and New York Law
The chief aims of the MOLST initiative are to (1) promote
communication and planning for decisions near the end of life
between seriously ill patients and their physicians; (2) establish
a single, uniform approach to documenting all physician orders
pertaining to end-of-life care; (3) make those orders transferable
4. EXCELLUS BLUECROSS BLUESHIELD, MEDICAL ORDERS FOR LIFE SUSTAINING
TREATMENT GUIDEBOOK 3 (2006), available at https://www.compassionandsupport.
org/pdfs/professionals/training/MOLST_Booklet%20.pdf [hereinafter EXCELLUS,
GUIDEBOOK].
5. Id.
6. Id. at 1.
7. New York Department of Health, Table 32a: Death Summary Information
by Age, New York State – 2006 (June 2008), available at www.health.state.ny.us/
nysdoh/vital_statistics/2006/table32a.htm.
8. See, e.g., THE HARPER’S INDEX BOOK 160 (Charis Conn, George Plimpton &
Lewis H. Lapham eds., 2000); Thomas J. Prendergast, Withholding or Withdrawal
of Life-Sustaining Therapy, HOSP. PRACT., June 15, 2000, at 91-92, 95-100, 102.
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across care settings; and (4) replace New York’s non-hospital
DNR form with a universal DNR form regardless of care setting.9 Implementing the new law, the New York State Department of Health (“DOH”) approved and adopted the MOLST
form for use throughout New York for most patients.10 Though
hospitals are not per se required to use the form, the imprimatur of the DOH makes it likely that most hospitals will do so.11
In addition, the MOLST form is already in use in many communities, where its shared adoption fosters transferability of orders and continuity across care settings.12 The MOLST form is
modeled after Oregon’s Physician Orders for Life-Sustaining
Treatment (“POLST”).13 Some version of the POLST program
has been adopted or is presently under consideration in a number of states.14
A. DNR Orders
The MOLST law adds to and seeks to implement a patchwork of New York laws governing end-of-life decisions. A core
feature of the MOLST form is its documentation of DNR decisions governed by the DNR law.15 Under that law, competent
patients have the right to refuse interventions to restore heart
function or sustain ventilation in the event of cardio-pulmonary
arrest.16 Family members, in the order of priority set forth by
law (e.g., health care proxy, followed by the spouse, then an
9. N.Y. State Dep’t of Health, Medical Orders for Life Sustaining Treatment
(MOLST), http://www.health.state.ny.us/professionals/patients/patient_rights/
molst/ (last visited Apr. 20, 2009) [hereinafter N.Y. State Dep’t of Health, MOLST].
10. Id. See also infra app. A.
11. Id.
12. Id.
13. Patricia A. Bomba, Medical Orders for Life-Sustaining Treatment
(MOLST): A Paradigm Shift in Advance Care Planning, N.Y. ST. B.A. HEALTH L.J.,
Summer/Fall 2006, at 39-51.
14. Susan E. Hickman et al., The POLST (Physician Orders for Life-Sustaining Treatment) Paradigm to Improve End-of-Life Care: Potential State Legal
Barriers to Implementation, 36 J.L. MED. & ETHICS 119, 119-25 (2008).
15. See infra app. A. A 2006 transmittal letter from the DOH to all hospital
CEOs highlights that MOLST “can be used statewide by health care providers and
facilities as the legal equivalent of an inpatient Do Not Resuscitate (DNR) form.”
Letter from Martin J. Conroy, Dir., Bureau of Hosp. & Primary Care Servs., N.Y.
State Dep’t of Health et al., to Chief Executive Officers (Jan. 17, 2006), available at
http://www.health.state.ny.us/professionals/nursing_home_administrator/docs/dcl
_molst.pdf.
16. N.Y. PUB. HEALTH LAW § 2960 (McKinney 2007).
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adult child, and so on), may make DNR decisions on behalf of an
incompetent patient who is terminally ill (a prognosis of one
year or less of life remaining) or permanently unconscious, or
when resuscitation would be “medically futile” or impose an “extraordinary burden” on the patient.17 For example, many would
consider it an extraordinary burden (perhaps futile) to perform
CPR on an incapacitated, terminally ill patient with severe osteoporosis and advanced dementia or with advanced carcinoma
and metastases to the ribs.
Under New York’s DNR law, when the patient lacks decisional capacity, surrogate decision-makers are to base their decision on the patient’s wishes or, if the patient’s wishes are not
reasonably known, on the patient’s best interests.18 Only in the
absence of a surrogate decision-maker for the incompetent patient may the attending physician, with the concurrence of a
second physician, enter a DNR order on grounds of medical futility, commonly known as a two physician DNR order.19 Section A of the MOLST form calls upon patients and families to
make an initial choice that sets the tone for interpretation of
the remainder of the document: whether there is an order not to
attempt cardio-pulmonary resuscitation (“CPR”), including endotracheal intubation and electric shock of the heart (a DNR
order), or whether the patient would want full CPR (full code
status).20
For non-hospital patients who may experience cardiac arrest at home or elsewhere, the MOLST form is an alternative to
the standard one-page non-hospital DNR order form that has
been used in New York for the past two decades.21 Significantly, the MOLST form can be used to enter both hospital and
non-hospital DNR and DNI orders.22 Establishment of DNI orders, expressly authorized by the MOLST legislation, clarifies
prior confusion about the legal status of such orders, giving
emergency medical personnel clear authority to honor non-hos17. Id. § 2965.
18. Id.
19. Id. § 2966.
20. See infra app. A.
21. N.Y. PUB. HEALTH LAW § 2977(13) (McKinney Supp. 2009); Excellus
BlueCross BlueShield, supra note 1.
22. EXCELLUS, GUIDEBOOK, supra note 4, at 1.
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pital DNI orders.23 To this extent, the MOLST form extends the
reach of the right to refuse treatment.
B. Health Care Proxies
The right of competent patients to refuse unwanted bodily
interventions, including life-sustaining treatments, even when
others such as physicians may disagree with the patient’s decision, is well-established under both constitutional law and the
common law of self-determination.24 This right may be exercised by family members or other surrogate decision makers in
the event the patient loses decisional capacity (competence).25
The best way for a person to make his or her wishes count after
illness, disease, or injury has taken personal decision-making
ability away is to put those wishes in writing by completing an
advance directive. Advance directives, that is, a durable power
of attorney for health care (more commonly known as a proxy
directive), living will, or both, are recognized by statute in all
fifty states and the District of Columbia.26
23. Act of July 7, 2008, ch. 197, 2008 N.Y. Laws 197 (codified as amended at
N.Y. PUB. HEALTH LAW § 2977(13)); EXCELLUS, GUIDEBOOK, supra note 4, at 1.
24. See, e.g., Gray v. Romeo, 697 F. Supp. 580, 584-87 (D.R.I. 1988); Rasmussen v. Fleming, 741 P.2d 674, 681-83 (Ariz. 1987); Conservatorship of Drabick, 245
Cal. Rptr. 840, 844-49 (Ct. App. 1988); In re Estate of Longeway, 549 N.E.2d 292,
294-302 (Ill. 1989); In re Quinlan, 355 A.2d 647, 662-69 (N.J. 1976). The U.S. Supreme Court affirmed and reinforced this constitutional right and the foundations
of the end-of-life consensus that had developed under state law in Cruzan v. Dir.,
Mo. Dep’t of Health, 497 U.S. 261, 269-87 (1990). For discussion of the law governing end-of-life decisions, see NORMAN L. CANTOR, ADVANCE DIRECTIVES AND THE
PURSUIT OF DEATH WITH DIGNITY ch. 1 (1993); ROBERT S. OLICK, TAKING ADVANCE
DIRECTIVES SERIOUSLY ch. 1 (2001); Alan Meisel, The Legal Consensus about Forgoing Life-Sustaining Treatment: Its Status and Its Prospects, 2 KENNEDY INST. ETHICS J. 309 (1992). These same principles have been recognized in decisions from
the New York Court of Appeals in In re Westchester County Med. Ctr (O’Connor),
531 N.E.2d 607, 611-12 (N.Y. 1988), and In re Storar, 420 N.E.2d 64, 70 (N.Y.
1981). However, as discussed below, by requiring surrogate decision makers not
appointed as health care proxy to show the patient’s wish to refuse life-sustaining
treatment by clear and convincing evidence, the O’Connor decision creates significant obstacles to implementation and recognition of the incompetent patient’s
right to refuse treatment. See infra notes 43-48 and accompanying text.
25. See sources cited supra note 24.
26. The vast majority of state laws recognize both proxy directives and living
wills. See Am. Bar Ass’n, Comm’n on Law and Aging, Health Care Power of Attorney and Combined Advance Directive Legislation as of Sept. 1, 2008, http://www.
abanet.org/aging/legislativeupdates/pdfs/HCPA-CHT.pdf. Three states, New York,
Massachusetts, and Michigan recognize by statute only the proxy directive. See id.
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Under New York’s health care proxy law, a competent adult
(eighteen or older) may plan ahead for important health care
decisions by designating a spouse, trusted family member, or
friend as health care agent (more commonly known as the
proxy) to make decisions on his or her behalf in the event of
future decisional incapacity.27 The patient’s proxy is clothed
with authority to make any and all health care decisions the
patient could make if able to do so.28 First and foremost, the
proxy is to decide in accordance with the patient’s wishes or, if
the patient’s wishes are not reasonably known, in the patient’s
best interests.29
The New York proxy law is among the minority of state advance directive laws that carve out special requirements for the
forgoing of artificial fluids and nutrition.30 New York’s law creates a presumption that artificial fluids and nutrition are to be
provided unless there is some reasonable evidence of the patient’s refusal of this medical modality. Specifically, the law
states that “if the [patient’s] wishes regarding the administration of artificial nutrition and hydration are not reasonably
known and cannot with reasonable diligence be ascertained,”
the proxy has no authority to refuse such measures.31 The
MOLST form offers a uniform mechanism for documenting patient, proxy, or legally recognized surrogate decisions regarding
artificially provided fluids and nutrition, CPR, mechanical ventilation, antibiotics, and other life-sustaining interventions.32
Decisions on behalf of an adult patient who lacks decisional capacity are to be documented on the MOLST supplemental
form.33
27. N.Y. PUB. HEALTH LAW § 2981(1) (McKinney 2007).
28. Id. § 2982(1).
29. Id. § 2982(2)(a), (b).
30. The other states include Nebraska, Ohio, and Oklahoma. See NEB. REV.
STAT. § 30-3418 (1997); OHIO REV. CODE ANN. § 2133.09 (WEST 1994); OKLA. STAT.
tit. 63, § 3080.4 (2004).
31. N.Y. PUB. HEALTH LAW § 2982(2)(b).
32. See infra app. A.
33. See Medical Orders for Life-Sustaining Treatment (MOLST), “Supplemental” Documentation Form for Adults, available at https://www.excellusbcbs.com/
wps/wcm/resources/file/ebd8584ee65b0e9/molst_adult_form.pdf (last visited Apr.
20, 2009) [hereinafter MOLST Supplemental Form]. There is also a separate
MOLST form for end-of-life decisions for minors (patients under the age of eighteen) that is beyond the scope of this paper. See Medical Orders for Life-Sustaining Treatment (MOLST), “Supplemental” Documentation Form for Minors,
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Under the Patient Self-Determination Act (“PSDA”),34 hospitals are required to document whether the patient has an advance directive, such as a health care proxy, living will (also
known as an instruction directive) or a combination of the two.35
This is a practice commonly known as documenting the patient’s “advance directive status.” The MOLST form incorporates this requirement by having health care providers indicate
whether a patient has executed an advance directive.36 If the
patient’s advance directive has been obtained and made a part
of the medical record, the MOLST form provides a unified
means to effectuate proxy decisions (or the terms of a living
will) by entering them as current physician’s orders on the
form.37 Section D of the MOLST form expressly recognizes that
an advance directive is “an additional document that provides
guidance for treatment measures if [the patient] loses decisionmaking capacity” and provides space to record whether the patient has an advance directive.38 Still, as discussed below, introduction of the MOLST form has created confusion about the
differences between a health care proxy and a MOLST form.39
C. Surrogate Decisions Without a Proxy Appointment
Most citizens have not executed a proxy directive or a living
will. For many years, national studies have found that approximately twenty percent of adults eighteen and older use advance
directives.40 Although recent studies suggest that the use of adavailable at http://www.ohsu.edu/polst/programs/documents/MOLST_Minor_Supp
_Form_Approved_9.11_.08_.kr_.pdf.
34. 42 U.S.C. § 1395cc (2006).
35. Id. § 1395cc(f)(1)(B).
36. See infra app. A.
37. See infra app. A.
38. See infra app. A.
39. See N.Y. State Dep’t of Health, Frequently Asked Questions, http://www.
health.state.ny.us/professionals/patients/patient_rights/molst/frequently_asked_
questions.htm (last visited Apr. 20, 2009) [hereinafter N.Y. State Dep’t of Health,
FAQ].
40. See, e.g., Joanne Lynn and Joan Teno, After the Patient Self-Determination
Act: The Need for Empirical Research on Formal Advance Directives, HASTINGS
CENTER REP., Jan.-Feb. 1993, at 20-21. See also Bomba, supra note 13, at 41 (summarizing several other recent surveys).
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vance directives nationally and in New York has increased,41
most New Yorkers have not executed a health care proxy.42
Family members called upon to make end-of-life decisions
for incapacitated loved ones who have not completed a health
care proxy form typically find that New York law erects a substantial barrier to their rightful place at the bedside. That barrier, established by the New York Court of Appeals in In re
Westchester County Medical Center (O’Connor)43 and In re
Storar,44 is the requirement that families (or other surrogate decision makers) provide clear and convincing evidence that their
incompetent dying parent, spouse, or sibling would want lifesustaining treatment withheld or withdrawn.45 According to
the O’Connor court, this means that families must show that
patients, while competent, “held a firm and settled commitment
to the termination of life supports under the circumstances like
those presented.”46 In practical terms, to truly satisfy this standard, families need to show that their loved one’s values and
statements refusing life-sustaining treatment closely fit his or
her current medical circumstances and were consistently expressed over time.47
Rigidly applied, this is a significant burden for many families to meet and sometimes makes physicians hesitant to comply with family decisions, even when they agree that
terminating life support is ethically justified and in the patient’s best interests. In hospital practice, disagreement or uncertainty about whether this standard is met often triggers an
ethics consultation. This process typically leads to resolution of
the dilemma. However, under the governing law, when a patient has no health care proxy or other written evidence of his or
41. See, e.g., Press Release, Pew Research Ctr., More Americans Discussing—
and Planning—End-of-Life Treatment: Strong Public Support for Right to Die
(Jan. 5, 2006), available at http://people-press.org/reports/pdf/266.pdf.
42. See EXCELLUS BLUECROSS BLUESHIELD, END-OF-LIFE CARE SURVEY OF UPSTATE NEW YORKERS: ADVANCE CARE PLANNING VALUES AND ACTIONS: SUMMARY
REPORT 3 (2008), available at https://www.excellusbcbs.com/wps/wcm/resources/
file/eb856805385613f/End%20of%20Life%20survey-EX.pdf (finding that forty-two
percent of upstate New Yorkers have executed a health care proxy).
43. 531 N.E.2d 607 (N.Y. 1988).
44. 420 N.E.2d 64 (N.Y. 1981).
45. In re O’Connor, 531 N.E.2d at 613-14, In re Storar, 420 N.E.2d at 72.
46. In re O’Connor, 531 N.E.2d at 613.
47. See id. at 614-15.
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her wishes, the utility of the MOLST form for New York families may be limited by the clear and convincing evidence standard.48 The MOLST form itself acknowledges these limitations
but does not change them.49
It is important to note that the clear and convincing evidence standard does not apply to decisions made by a health
care proxy or to decisions to authorize DNR orders.50 Nor can
this language be found in recent amendments authorizing family members to make end-of-life decisions on behalf of loved
ones with mental retardation or developmental disability.51 In
each case, statutory law has rejected this standard as inappropriate and has crafted a more family-friendly approach to decision-making.52 However, absent a change in the law or more
extensive use of health care proxies, the clear and convincing
evidence standard will remain a major legal obstacle for surrogates and for full and effective implementation of the MOLST
form.
D. Patients With Mental Retardation and Developmental
Disability
The MOLST law acknowledges the “carve out” of more specific rules found elsewhere in New York law that govern decisions near the end of life for patients with mental retardation
(“MR”) or developmental disability (“DD”).53 Pursuant to two
recent amendments to the Surrogate’s Court Procedure Act,54
“qualified” family members may act as guardians (in stated order of priority) without formal court appointment, to make
health care decisions, including decisions near the end of life,
48. See In re O’Connor, 531 N.E.2d at 613-14; In re Storar, 420 N.E.2d at 72.
49. See infra app. A.
50. See N.Y. PUB. HEALTH LAW §§ 2960, 2981(1) (McKinney 2007 & Supp.
2009).
51. See Act of July 7, 2008, ch. 262, 2008 N.Y. Laws 262 (codified as amended
at N.Y. SURR. CT. PROC. ACT § 1750-b (McKinney Supp. 2009)); Act of July 3, 2007,
ch. 105, 2007 N.Y. Laws 105 (codified as amended at N.Y. SURR. CT. PROC. ACT
§ 1750-b).
52. See N.Y. SURR. CT. PROC. ACT § 1750-b; N.Y. PUB. HEALTH LAW §§ 2960,
2981(1).
53. EXCELLUS, GUIDEBOOK, supra note 4, at 2.
54. Act of July 7, 2008, ch. 262, 2008 N.Y. Laws 262 (codified as amended at
N.Y. SURR. CT. PROC. ACT § 1750-b); Act of July 3, 2007, ch. 105, 2007 N.Y. Laws
105 (codified as amended at N.Y. SURR. CT. PROC. ACT § 1750-b).

9

\\server05\productn\P\PLR\29-3\PLR308.txt

554

unknown

Seq: 10

PACE LAW REVIEW

30-JUN-09

14:28

[Vol. 29:545

for seriously ill loved ones with MR or DD.55 Decisions to forgo
life-sustaining treatment may be made when the patient is terminally ill, permanently unconscious, or has an irreversible
condition requiring life-sustaining treatment that will continue
indefinitely.56 Families must base their decision on the patient’s best interests, taking into account the patient’s wishes
and values to the extent known.57
The MOLST supplemental form for adults can be used to
document decisions for patients with MR or DD who lack decisional capacity.58 Importantly, diagnosis of MR or DD does not
create a presumption of decisional incapacity. Rather, this is
determined on a case-by-case basis, and patients with cognitive
impairment due to mental retardation or developmental disability may be able to make their own health care decisions and/
or designate a loved one or trusted friend as their health care
proxy.59 The MOLST form incorporates the legal requirement
that a psychiatrist or psychologist, qualified by specialized
training or experience with MR or DD patients, must confirm
and document that the patient lacks decisional capacity.60
II. Challenges and Legal Barriers
As already noted, the major barrier to full and effective use
of the MOLST form is New York’s failure to fully empower families to make decisions near the end of life.61 In 1992, the New
York State Task Force on Life and the Law recommended enactment of legislation that would empower families confronting
55. N.Y. SURR. CT. PROC. ACT § 1750-b. Qualified family members are those
who have “a significant and ongoing involvement in the person’s life.” Id.
56. Id.
57. Id. See also 14 N.Y. COMP. CODES R. & REGS. tit. 14, § 633.10(a) (2009).
58. See MOLST Supplemental Form, supra note 33. MOLST does not apply to
patients under the auspices of the Office of Mental Health or who are residents of
an Office of Mental Retardation and Developmental Disability facility. See id.
59. N.Y. State Dep’t of Health, FAQ, supra note 39.
60. 14 N.Y. COMP. CODES R. & REGS. tit. 14, § 633.10(a). For further discussion of the amendments to the Surrogate’s Court Procedure Act, see Lawrence R.
Faulkner, End of Life Healthcare for Persons with Developmental Disabilities: The
New York Policies (Network on Ethics and Intellectual Disability Edmonton, Can.),
Summer 2007, at 1.
61. See supra notes 43-49 and accompanying text.
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the burdens of these decisions.62 Much of the Task Force’s original proposal is contained in a bill, known as the Family Health
Care Decisions Act, that has been on the legislative agenda for
more than fifteen years.63 Absent this critical change in the
law, the MOLST form will be of limited value to the many dying
patients who lack decisional capacity, who do not have a written
health care proxy, and whose families cannot present clear and
convincing evidence that their spouse, father, mother, or sibling
would refuse life-sustaining treatment.
Further challenges are presented by the interface of the
MOLST form with health care proxies. The following case illustrates that the MOLST form can sometimes blur the line between a physician’s orders based on contemporaneous patient
wishes and proxy decision making and that a MOLST form can
even be confused with a living will.64
Mr. B is a fifty-nine-year-old man with a history of lung
cancer who was admitted to Goodwill Hospital. His physician
completed a MOLST form, documenting Mr. B’s wish not to be
resuscitated in the event of cardiac arrest. At the same time,
Mr. B wanted other aggressive interventions, including a feeding tube, if necessary. One month later, he designated his sister
as his health care proxy. Shortly thereafter, Mr. B was transferred to WeCare Hospital for an oncology follow up. Two days
after admission, he suffered a stroke and lost decisional capacity, although he was still able to communicate and interact with
others to an extent.
The attending physician believes that Mr. B is terminally
ill but could live another six months with a feeding tube. Mr.
B’s health care proxy gives his sister authority to “make any
and all health care decisions for me, except to the extent I state
otherwise,” in accordance with Mr. B’s wishes and best interests. The standard form document gives no indication of Mr. B’s
62. N.Y. STATE TASK FORCE ON LIFE & THE LAW, WHEN OTHERS MUST CHOOSE:
DECIDING FOR PATIENTS WITHOUT CAPACITY (1992) (offering a comprehensive analysis of New York law and practice concerning surrogate decision making and the
failure to empower families at the bedside).
63. Family Decision Coalition, Family Health Care Decisions Act, http://www.
familydecisions.org/fhcda-bill.html (last visited Apr. 20, 2009). See also Assemb.
7729, 232nd Sess. (N.Y. 2009), S. 3164, 232nd Sess. (N.Y. 2009).
64. This case is adapted from an ethics consultation provided by one of the
authors.
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specific wishes regarding a feeding tube. Mr. B’s sister refuses
the feeding tube, stating, “He told me this is not what he
wanted.” Two nurses caring for Mr. B object. They insist that
the MOLST documents are binding physician orders and constitute Mr. B’s informed consent to the feeding tube. Mr. B’s sister
strenuously insists she is not bound by the MOLST form and
that it does not represent her brother’s wishes as she understood them when she was made his health care proxy.
Which document controls—the MOLST form or the health
care proxy? And to what extent is the proxy bound by the terms
of the earlier MOLST form? The nurses’ position is understandable. The MOLST form is designed with contemporaneous consent of the patient or surrogate in mind.65 Once completed, the
MOLST form has no automatic expiration date.66 When Mr. B
transferred from Goodwill, the MOLST form and his end-of-life
wishes went with him. Still, Mr. B’s sister has the better argument. We can wonder why the MOLST form was not reviewed
or changed when Mr. B signed his proxy, but regardless, his validly executed document gives his sister clear authority under
our proxy law.67 She may and should look to the prior MOLST
form for guidance, but she is not bound by it. Her charge is to
ascertain and honor her brother’s wishes based on the totality
of his statements, beliefs, and values over time. The MOLST
form is in this case akin to a living will. It offers written evidence of Mr. B’s wishes at the time, but it has only qualified
legal standing as a statement of the patient’s wishes.68 The
later proxy document controls.69 Further, good medical practice
dictates that the Goodwill physician’s orders should be reviewed
by Mr. B’s current attending physician. The orders are presumptively, but not conclusively, binding. They may be
65. See EXCELLUS, GUIDEBOOK, supra note 4, at 1; N.Y. State Dep’t of Health,
MOLST, supra note 9.
66. See EXCELLUS, GUIDEBOOK, supra note 4, at 11.
67. See N.Y. PUB. HEALTH LAW § 2981(1) (McKinney 2007).
68. The New York proxy law does not recognize living wills. Written statements of the patient’s wishes, such as a living will, are important evidence of the
patient’s wishes and may under the circumstances meet the “clear and convincing
evidence” test. See In re Westchester County Med. Ctr. (O’Connor), 531 N.E.2d
607, 613-14 (N.Y. 1988).
69. See N.Y. STATE DEP’T OF HEALTH, BUREAU OF EMERGENCY MED. SERVS.,
POLICY STATEMENT 2 (2008), available at http://www.health.state.ny.us/nysdoh/
ems/pdf/08-07.pdf.
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changed, particularly if the patient’s condition has changed as
Mr. B’s has.
The above viewpoint is expressly supported by the requirement that the MOLST form be periodically reviewed, and, if appropriate, modified with new orders.70 Review and modification
are specifically required upon transfer from another facility.71
A WeCare attending physician should either complete a new
MOLST form or document any changes on the existing MOLST
form.72
It is useful to further compare and contrast the MOLST
form and the health care proxy. The MOLST form is intended
as a mechanism for documenting physician orders to implement
decisions made by the competent patient who is chronically ill
or dying.73 The supplemental MOLST form is used to document
physician orders to implement decisions of a health care proxy
or other appropriate surrogate on behalf of an incompetent patient.74 The MOLST form is effective upon proper completion by
the physician.75 By contrast, the purpose of health care proxies
and living wills is to direct medical decisions regarding the end
of life in the event of future incapacity.76 Proxies and living
wills are ideally written when the individual is in good health.
An important trigger for planning ahead is diagnosis of a
chronic illness or disease. In addition, many physicians and patients perceive the MOLST form as complex to complete. This
perception creates further confusion about its proper use and
how it differs from advance directives. The confusion is not surprising, especially so when the form was executed some time in
the past and at another facility, as in Mr. B’s case.
Advance directives and the MOLST form should be understood as complementary tools for documenting patients’ decisions near the end of life. Neither is a substitute for the other.
Failure to write an advance directive may mean that the physician cannot use the MOLST form to enter orders based on the
now-incompetent patient’s wishes and values. The DOH,
70.
71.
72.
73.
74.
75.
76.

N.Y. State Dep’t of Health, FAQ, supra note 39.
Id.
Id.
Id.
Id.
Id.
Id.
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health care providers, and policy leaders should make the similarities and differences between a MOLST form and a health
care proxy, and their complementary roles in decision making
near the end of life, an educational priority.
III. Conclusion
The MOLST initiative offers a standardized DNR form that
is effective across care settings, both in the hospital and the
home, and holds the promise of improving end-of-life care
through the integration of physician orders for all life-sustaining treatments. All of this is achieved through the implementation of one easily recognized document.77 The key to the
MOLST form’s success will be whether physicians use the form
effectively and proactively to communicate with patients and
families, to manage the difficult task of giving “bad news,” and
to work with patients and families to ease the burdens of decision making.
The “pink form” serves as a reminder of the importance of
the informed consent process, as well as establishing a health
care proxy, and of the complementary ways a MOLST form and
a health care proxy can be used to make patients’ wishes count
near the end of life. Physicians, nurses, emergency medical
technicians, and others across the state should receive in-service training in the use of the MOLST form, stressing that the
MOLST form is a key tool in the larger dialogue about decisions
near the end of life. Still, the promise of the MOLST initiative
is hampered by the troubling gap in New York law that burdens
family members with the clear and convincing evidence standard if they have not been appointed as the patient’s health
care proxy (agent).78 New York case law too often disenfranchises families from their rightful place at the bedside to
make decisions on behalf of their loved ones.79 Enactment of
the Family Health Care Decisions Act would address this critical flaw in New York law.80

77. See infra app. A.
78. See N.Y. State Dep’t of Health, FAQ, supra note 39. See also supra notes
43-49 and accompanying text.
79. See supra notes 43-49 and accompanying text.
80. See supra notes 61-63 and accompanying text.
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SEND FORM WITH PATIENT/RESIDENT WHENEVER TRANSFERRED OR DISCHARGED
Last Name/First/Middle Initial of Patient/Resident

MOLST
Medical Orders for Life-Sustaining Treatment
Do-Not-Resuscitate (DNR) and
other Life-Sustaining Treatments (LST)
This is a Physician’s Order Sheet based on this patient/resident’s current medical condition
and wishes. It summarizes any Advance Directive. If Section A is not completed, there are
no restrictions for this section. When the need occurs, first follow these orders, then contact
physician. Review the entire form with the patient. Any section not completed implies full
treatment for that section. WARNING: If patient lacks medical decision-making capacity as
a result of mental retardation or developmental disability or has a legal guardian, specific,
mandatory procedures need to be followed. Review information and seek legal counsel.

Address
City/State/Zip
Patient/Resident Date of Birth
(mm/dd/yyyy)

Gender

M

F

Unique Patient Identifier (Last 4 SSN)

LE

This form should be reviewed and renewed periodically, as required by New York State and Federal law or regulations, and/or if:
¾ The patient/resident is transferred from one care setting or care level to another, or
¾ There is a substantial change in patient/resident health status (improvement or deterioration), or
¾ The patient/resident treatment preferences change

Section RESUSCITATION INSTRUCTIONS (ONLY for Patients in Cardiopulmonary Arrest):

A
Check One
Box Only

(If patient/resident has no blood pressure, no pulse and no respiration) This form can be used in all settings, including community.

Do Not Resuscitate (DNR)*/Allow Natural Death *[DNR = No CPR, endotracheal intubation or mechanical ventilation]
Full Cardio-Pulmonary Resuscitation (CPR) [No Limitations; accepts intubation and mechanical ventilation]
* For incapacitated adults; and/or for therapeutic or medical futility exceptions; and/or for residents of OMH, OMRDD or correctional facilities, also
complete relevant sections of Supplemental DNR Documentation Form for Adults. For residents of OMRDD without capacity in the community, also
complete NYSDOH Nonhospital DNR form. For minor patients, also complete Supplemental DNR Documentation Form for Minors.

Section DNR (CPR) CONSENT OF PATIENT/RESIDENT WITH DECISION-MAKING CAPACITY:
____________________________________

___________________________ _______________

Check if verbal consent *

Patient/Resident Signature

Print Patient/Resident Name

Date

_______________________________________________________ _________________________________________ ______________________
Witness of Patient/Resident Signature or Verbal Consent
Print Witness Name
Date
_______________________________________________________ _________________________________________ ______________________
Witness of Patient/Resident Signature or Verbal Consent
Print Witness Name
Date
*Patient with capacity can provide verbal consent in the presence of two adult witnesses. Written consent requires only one witness signature.
If verbal consent, one witness must be a physician. In facility, physician must be affiliated with the facility, e.g. resident physician qualifies.

DNR (CPR) CONSENT OF HEALTH CARE AGENT (HCA) OR SURROGATE DECISIONMAKER FOR PATIENT / RESIDENT WITHOUT DECISION-MAKING CAPACITY: This document
reflects what is known about the patient/resident’s treatment preferences. For Patient/Resident without decision-making capacity, or when
medical futility or therapeutic exception is used, Supplemental MOLST Documentation Form MUST be completed and should always
accompany this MOLST Form. If patient/resident has a legal and valid DNR previously completed while patient/resident had capacity,
attach to MOLST.
Prior DNR form attached
Supplemental Documentation Form completed

A

Complete
one of the
subsections
of Section B

P

Patient/
Resident/
Health Care
Agent or
Surrogate
DecisionMaker
Consent for
Section A

Section A reflects my treatment preferences.

M

B

________________________________ ________________________
HCA/Surrogate Signature

Check if verbal consent

Print Name

____________________
Date

___________________________________________________________
________________________________ ________________________ ____________________
Relationship to Patient/Resident:

Witness Signature
(Must witness HCA/surrogate signature or verbal/telephone consent)

Print Witness Name

Date

S

Section Physician Signature for Sections A and B:

C

Physician
Signature
for Section A
and B

____________________________________

___________________________ _______________

Physician Signature
Print Physician Name
Date
(Must Witness Patient/Resident Signature or obtain Verbal Consent. Resident physician signature must be co-signed by licensed physician.)

Physician License #: ____________________________________

Physician Phone/Pager #: __________________________________________

It is the responsibility of the physician to determine, within the appropriate period, (see below) whether this order continues to be
appropriate, and to indicate this by a note in the person’s medical chart. The issuance of a new form is NOT required, and under the law
this order should be considered valid unless it is known that it has been revoked. This order remains valid and must be followed, even if it
has not been reviewed within the appropriate time period. The physician must review these orders as follows: Hospital: at least every
7 Days; Nursing Home/Skilled Nursing Facility: at least every 60 Days; Nonhospital/Community Setting: at least every 90 Days

Section ADVANCE DIRECTIVES:

D
B-1620

Patient/Resident has completed an additional document that provides
guidance for treatment measures if he/she loses medical decision-making capacity:

Health Care Proxy
Revised August 2008

Living Will

Other Written Documentation or Oral Advance Directive

MOLST is consistent with PHL§2977(13) and cannot be altered.
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HIPAA Permits Disclosure of MOLST to Other Health Care Professionals & Electronic Registry as necessary for treatment.

Section

E

ORDERS FOR OTHER LIFE-SUSTAINING TREATMENT AND FUTURE
HOSPITALIZATION: (If patient/resident has pulse and/or is breathing)
Review patient’s goals and patient’s choice of interventions and then complete orders for appropriate subsections. Blank
subsections can be completed at a later date. If patient has decision-making capacity, patient should be consulted prior to
treatment or withholding thereof. After confirming consent of appropriate decision-maker, obtain signature or verbal
consent and complete the consent section of Section E, at the bottom of this page. Physician must sign and date each
subsection at the time of completion.

ADDITIONAL TREATMENT GUIDELINES:

(Comfort measures are always provided.)

Comfort Measures Only – The patient is treated with dignity and respect. Reasonable measures are made to offer food and
fluids by mouth. Medication, positioning, wound care, and other measures are used to relieve pain and suffering. Oxygen, suction and
manual treatment of airway obstruction are used as needed for comfort. Do Not Transfer to hospital for life-sustaining treatment.
Transfer if comfort care needs cannot be met in current location.

LE

Physician
may
complete
form with
patient who
has capacity
or with
Health Care
Agent.
Include
Section E
consent.

Limited Medical Interventions - Oral or intravenous medications, cardiac monitoring, and other indicated treatments
are provided except as specified in Sections A or E. Guidance about acceptable/unacceptable interventions relevant
to this patient/resident may be written under “Other Instructions” below. May consider less invasive airway support
(e.g. CPAP, BIPAP). Transfer to the hospital as indicated.

No Limitations on Medical Interventions - All indicated treatments
are provided except as specified in Sections A. Transfer to the hospital is
indicated, including intensive care.

MD Signature:

Date:

M

P

ADDITIONAL INTUBATION AND MECHANICAL VENTILATION INSTRUCTIONS: If patient/
Physician may resident chooses DNR, review all options if patient/resident has progressive or impending pulmonary failure without acute
complete form cardiopulmonary arrest. If patient chooses full CPR, review options of trial and long-term intubation & mechanical ventilation:
Do Not Intubate (DNI)
for
(Review available symptomatic treatment of dyspnea: oxygen, morphine, etc.)
incapacitated
patients
A trial period of intubation and ventilation
A trial of BIPAP
A trial of CPAP
without Health
(Discuss duration of trial and document in other instructions.)
Care Agent
MD Signature:
Date:
Intubation and long-term mechanical ventilation, if needed
only with
clear and
convincing
FUTURE HOSPITALIZATION / TRANSFER: (For long-term care residents and home patients)
evidence.
No hospitalization unless pain or severe symptoms cannot be otherwise controlled.
Include
MD Signature:
Date:
Section E
Hospitalization with restrictions outlined in Sections A and E.
consent.
ARTIFICIALLY ADMINISTERED FLUIDS AND NUTRITION:

(If Health Care Agent makes

decision, it must be based on reasonable knowledge of patient/resident’s wishes.)

No feeding tube (offer food/fluids as tolerated)
A trial period of feeding tube
Long-term feeding tube, if needed

A

Physician
should
consult legal
counsel for
MR/DD
patients
without
capacity. See
Surrogate’s
Court
Procedure
Act §1750-b.

No IV Fluids (offer food/fluids as tolerated)
A trial of IV fluids
MD Signature:

Date:

MD Signature:

Date:

ANTIBIOTICS:

No antibiotics (except for comfort)

Antibiotics

OTHER INSTRUCTIONS:

S

(May include additional guidelines for starting or stopping treatments in
sections above or other directions not addressed elsewhere.)
__________________________________________________________________________________________________
__________________________________________________________________________________________________
__________________________________________________________________________________________________
MD Signature:

Date:

CONSENT FOR SECTION E OF PERSON NAMED IN SECTION B: Significant thought has
been given to life-sustaining treatment. Patient/resident preferences have been expressed to the physician and this

Section E document reflects those treatment preferences. As the medical decision-maker, I confirm that the orders
Consent documented above in Section E reflect patient/resident’s treatment preferences.
___________________________
Signature

B-1620

Revised August 2008

https://digitalcommons.pace.edu/plr/vol29/iss3/10

Check if verbal consent

__________________________
Print Name

MOLST is consistent with PHL§2977(13) and cannot be altered.

__________________
Date
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SEND FORM WITH PATIENT/RESIDENT WHENEVER TRANSFERRED OR DISCHARGED

RENEW / REVIEW INSTRUCTIONS

Last Name/First/Middle Initial of Patient/Resident

MOLST (DNR and Life-Sustaining Treatment)

Address

This form should be reviewed and renewed periodically, as required by
New York State and Federal law or regulations, and/or if:
¾ The patient/resident is transferred from one care setting or care
level to another, or
¾ There is a substantial change in patient/resident health status
(improvement or deterioration), or
¾ The patient/resident treatment preferences change

City/State/Zip
Patient/Resident Date of Birth
(mm/dd/yyyy)

Gender

M

F

Unique Patient Identifier (Last 4 SSN)

How to Complete the MOLST Form

LE

¾MOLST must be completed by a health care professional, based on patient preference and medical indications.
¾Follow the 8-Step MOLST Protocol found at www.CompassionandSupport.org.
¾MOLST must be signed by a NYS licensed physician to be valid. Verbal orders are acceptable with follow-up signature by a
physician in accordance with facility/community policy.
¾If patient/resident has a legal and valid DNR previously completed while patient/resident had capacity, attach to MOLST.
¾Use of original form is strongly encouraged. Photocopies, FAXes and an electronic representation of the original signed
MOLST are legal and valid.

How to Review MOLST Form:

Review Sections A through E
Complete Section F below:
2a. If no changes, sign, date and check the “No Change” box.
2b.For additions to Section E “optional” directives, complete the relevant subsections(s) after securing consent from
the appropriate decision-maker, sign and date subsection(s) in Section E. Then sign, date and check “ChangesAdditions only” in box below.
2c.For substantive changes, (i.e. reversal of prior directive), write “VOID” in large letters on pages 1 and 2, and
complete a new form. Check box marked “FORM VOIDED, new form completed”. (RETAIN voided MOLST
form in chart or medical record, or as required by law.)
2d.If this form is voided and no new form is completed, full treatment and resuscitation will be provided. Write
“VOID” in large letters on pages 1 and 2 and check box marked “FORM VOIDED, no new form.” (RETAIN
voided MOLST form in chart or medical record, or as required by law.)
For detailed information about the MOLST Program, view www.CompassionandSupport.org.

M

P

Step 1:
Step 2:

Review of this MOLST Form

Section

F

Reviewer’s Name
and Signature

S

A

(Review
of this
Form)

Date

B-1620

Revised August 2008

Location of Review

Outcome of Review
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form

Pages 3 & 4 contain directions and renewals only.
Continue Section F on Page 4
MOLST is consistent with PHL§2977(13) and cannot be altered.
Page 3 of 4 MOLST-001-main-4-3
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SEND FORM WITH PATIENT/RESIDENT WHENEVER TRANSFERRED OR DISCHARGED

Review of this MOLST Form (Con’t from Page 3)

Section
Date

F

Reviewer’s Name
& Signature

Location of Review

S

A

M

P

LE

(Review
of this
Form)

Outcome of Review
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form
No Change
Changes – Additions only
FORM VOIDED, new form completed
FORM VOIDED, no new form

B-1620

Revised August 2008
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